Cargando…
Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics
The role of the immune system in cancer progression has become increasingly evident over the past decade. Chronic inflammation in the promotion of tumorigenesis is well established, and cancer-associated tolerance/immune evasion has long been appreciated. Recent developments of immunotherapies targe...
Autores principales: | Enninga, Elizabeth Ann L., Nevala, Wendy K., Holtan, Shernan G., Markovic, Svetomir N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549650/ https://www.ncbi.nlm.nih.gov/pubmed/26379664 http://dx.doi.org/10.3389/fimmu.2015.00424 |
Ejemplares similares
-
Fetal Sex-Based Differences in Maternal Hormones, Angiogenic Factors, and Immune Mediators During Pregnancy and the Postpartum Period
por: Enninga, Elizabeth Ann L, et al.
Publicado: (2015) -
Growth Modeling of the Maternal Cytokine Milieu throughout Normal Pregnancy: Macrophage-Derived Chemokine Decreases as Inflammation/Counterregulation Increases
por: Holtan, Shernan G., et al.
Publicado: (2015) -
Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma
por: Holtan, Shernan G., et al.
Publicado: (2011) -
Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017) -
Graft-versus-host disease: teaching old drugs new tricks at less cost
por: Farhan, Shatha, et al.
Publicado: (2023)